Oligonucleotide Synthesis Market - Current Trends and Outlook, 2025Posted by Ryan Shaw on June 24th, 2019 The global Oligonucleotide Synthesis Market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Continuous rise in usage of oligonucleotide synthesis across various aspects of human health management, from molecular diagnostics to therapeutics, is spurring revenue growth. The recent success of oligonucleotide-based drugs in medicine due to increase in number of FDA-approved products is anticipated to boost revenue generation in this market. As of September 2017, there are six approved oligonucleotide therapeutic products. A substantial number of oligos are being investigated for their usage in targeting various infectious diseases. For instance, dsDNA thioaptamers are reported to target the ribonuclease H (RNase H) domain of HIV-RT and are demonstrated to inhibit HIV-RT when used in vitro. In addition, demand for cancer-related thioapatmers that can detect presence as well as target tumor growth factors, such as TGF-β, is on a continuous rise. This, in turn, has led to increase in investments for exploring the significance of custom oligonucleotide synthesis in cancer research. To request a sample copy or view summary of this report, click the link below: Further key findings from the report suggest:
Grand View Research has segmented the global oligonucleotide synthesis market on the basis of product, application, end use, and region: Oligonucleotide Synthesis Product Outlook (Revenue, USD Million, 2014 - 2025)
Oligonucleotide Synthesis Application Outlook (Revenue, USD Million, 2014 - 2025)
Oligonucleotide Synthesis End-use Outlook (Revenue, USD Million, 2014 - 2025)
Oligonucleotide Synthesis Regional Outlook (Revenue, USD Million, 2014 - 2025)
Like it? Share it!More by this author |